Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics Autoinduction and Drug Interactions in Healthy Volunteers
Investigation of an Investigational Treatment for Migraine Management
Not Recruiting
18 years - 55 years
All
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Healthy
Age:
18 years - 55 years
Gender: All
Who can participate: Individuals aged 18 to 65 who experience migraines at least four times a month are eligible to participate. Key exclusions include individuals with a history of severe allergic reactions or those currently participating in another clinical trial.
Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The placebo is an inactive substance designed to resemble the investigational treatment. Participants will be required to attend regular clinic visits for monitoring and assessment.
Updated on
19 Feb 2024.
Study ID: 1010002585 (0704-14)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
